Towards next generation antisense oligonucleotides: mesylphosphoramidate modification improves therapeutic index and duration of effect of gapmer antisense oligonucleotidesBrooke A. Anderson, Punit P. Seth, William J. Drury et al.|Nucleic Acids Research|2021Cited by 129
Site-specific incorporation of 5′-methyl DNA enhances the therapeutic profile of gapmer ASOsGuillermo Vasquez, Punit P. Seth, Graeme C. Freestone et al.|Nucleic Acids Research|2021Cited by 47